tiprankstipranks
Trending News
More News >
Option Care Health (OPCH)
NASDAQ:OPCH
US Market

Option Care Health (OPCH) Ratios

Compare
547 Followers

Option Care Health Ratios

OPCH's free cash flow for Q4 2025 was $0.19. For the 2025 fiscal year, OPCH's free cash flow was decreased by $ and operating cash flow was $0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.53 1.53 1.70 1.77 1.76
Quick Ratio
0.96 0.96 1.20 1.33 1.36
Cash Ratio
0.28 0.28 0.53 0.56 0.52
Solvency Ratio
0.13 0.13 0.14 0.17 0.12
Operating Cash Flow Ratio
0.31 0.31 0.41 0.60 0.47
Short-Term Operating Cash Flow Coverage
0.00 0.00 49.66 15.29 10.54
Net Current Asset Value
$ -864.41M$ -864.41M$ -694.88M$ -812.43M$ -851.95M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.36 0.35 0.36
Debt-to-Equity Ratio
0.00 0.00 0.87 0.82 0.83
Debt-to-Capital Ratio
0.00 0.00 0.46 0.45 0.45
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.44 0.43 0.43
Financial Leverage Ratio
2.61 2.61 2.44 2.34 2.33
Debt Service Coverage Ratio
3.32 3.18 4.84 4.40 3.36
Interest Coverage Ratio
2.90 2.70 5.31 5.06 4.38
Debt to Market Cap
0.00 0.00 0.28 0.18 0.20
Interest Debt Per Share
0.74 0.79 7.45 6.86 6.68
Net Debt to EBITDA
-0.50 -0.49 2.03 1.74 2.65
Profitability Margins
Gross Profit Margin
19.26%19.26%20.27%22.81%21.98%
EBIT Margin
6.99%7.23%6.65%9.53%6.58%
EBITDA Margin
8.19%8.40%7.93%10.98%8.24%
Operating Profit Margin
5.98%5.98%6.44%7.31%6.09%
Pretax Profit Margin
5.01%5.01%5.67%8.34%5.22%
Net Profit Margin
3.67%3.67%4.24%6.21%3.82%
Continuous Operations Profit Margin
3.67%3.67%4.24%6.21%3.82%
Net Income Per EBT
73.38%73.38%74.69%74.45%73.17%
EBT Per EBIT
83.72%83.72%88.12%114.03%85.65%
Return on Assets (ROA)
6.01%6.01%6.19%8.02%4.66%
Return on Equity (ROE)
15.39%15.65%15.08%18.79%10.86%
Return on Capital Employed (ROCE)
12.87%12.87%12.18%11.61%9.01%
Return on Invested Capital (ROIC)
9.44%9.44%9.00%8.57%6.53%
Return on Tangible Assets
11.36%11.36%11.36%18.39%11.28%
Earnings Yield
4.43%4.12%5.32%4.43%2.76%
Efficiency Ratios
Receivables Turnover
11.93 11.93 12.20 10.00 10.30
Payables Turnover
7.13 7.13 6.52 7.79 8.13
Inventory Turnover
9.68 9.68 10.27 12.12 13.72
Fixed Asset Turnover
40.58 40.58 23.37 21.01 21.82
Asset Turnover
1.63 1.63 1.46 1.29 1.22
Working Capital Turnover Ratio
12.63 11.55 9.82 9.51 11.61
Cash Conversion Cycle
17.10 17.10 9.53 19.73 17.13
Days of Sales Outstanding
30.60 30.60 29.92 36.49 35.45
Days of Inventory Outstanding
37.70 37.70 35.55 30.11 26.60
Days of Payables Outstanding
51.20 51.20 55.94 46.88 44.92
Operating Cycle
68.29 68.29 65.47 66.61 62.05
Cash Flow Ratios
Operating Cash Flow Per Share
1.63 1.63 1.88 2.07 1.48
Free Cash Flow Per Share
1.52 1.63 1.68 1.84 1.28
CapEx Per Share
0.12 0.00 0.21 0.23 0.20
Free Cash Flow to Operating Cash Flow
0.93 1.00 0.89 0.89 0.87
Dividend Paid and CapEx Coverage Ratio
14.00 0.00 9.08 8.87 7.57
Capital Expenditure Coverage Ratio
14.00 0.00 9.08 8.87 7.57
Operating Cash Flow Coverage Ratio
0.00 0.00 0.27 0.32 0.23
Operating Cash Flow to Sales Ratio
0.05 0.05 0.06 0.09 0.07
Free Cash Flow Yield
5.10%5.13%7.23%5.46%4.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
22.59 24.29 18.79 22.58 36.20
Price-to-Sales (P/S) Ratio
0.83 0.89 0.80 1.40 1.38
Price-to-Book (P/B) Ratio
3.54 3.80 2.83 4.24 3.93
Price-to-Free Cash Flow (P/FCF) Ratio
19.62 19.51 13.83 18.30 23.47
Price-to-Operating Cash Flow Ratio
18.14 19.51 12.31 16.24 20.37
Price-to-Earnings Growth (PEG) Ratio
28.69 5.98 -1.08 0.28 5.65
Price-to-Fair Value
3.54 3.80 2.83 4.24 3.93
Enterprise Value Multiple
9.68 10.14 12.08 14.51 19.42
Enterprise Value
4.48B 4.81B 4.79B 6.85B 6.31B
EV to EBITDA
9.68 10.14 12.08 14.51 19.42
EV to Sales
0.79 0.85 0.96 1.59 1.60
EV to Free Cash Flow
18.65 18.61 16.63 20.80 27.18
EV to Operating Cash Flow
17.32 18.61 14.80 18.45 23.59
Tangible Book Value Per Share
-1.91 -1.91 -0.89 -2.54 -2.82
Shareholders’ Equity Per Share
8.39 8.38 8.18 7.94 7.65
Tax and Other Ratios
Effective Tax Rate
0.27 0.27 0.25 0.26 0.27
Revenue Per Share
35.73 35.70 29.13 24.04 21.78
Net Income Per Share
1.31 1.31 1.23 1.49 0.83
Tax Burden
0.73 0.73 0.75 0.74 0.73
Interest Burden
0.72 0.69 0.85 0.88 0.79
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.25 1.25 1.53 1.39 1.78
Currency in USD